EFFECT OF ENZYMES IN BUCCAL MUCOSA ON INSULIN BUCCAL ABSORPTION

杨天智,陈大兵,王丽茹,张强
DOI: https://doi.org/10.3321/j.issn:0513-4870.2001.12.014
2001-01-01
Journal of Chinese Pharmaceutical Sciences
Abstract:To evaluate the effect of proteolytic enzymes on the absorption of insulin in the buccal mucosa, the trichloroacetic acid (TCA) method was used to estimate the degradation of insulin under different conditions in the buccal mucosal ho mogenates. In vivo experiments estimating the enhancement of hypoglycaemic effect by enzyme inhibitora were also conducted.The results shewed that proteolytic enzymes in the buccal mucosa were less active than in the intestine. Bacitracin, aprotinin and sodium deoxycholate could inhibit the degradstion of insulin in the buccal mucosal honmogenates. The degradation of insulinin buccal mucosal homogenates of normal hamsters wes smaller than that of diabetic hamsters. In vivo experiments of hypogly caemia supported the in vitro results. When given buccally, bacitracin, aprotinin and sodium deoxycholate could increase the relative pharmacologipcal bioavailability of insulin. When co-administered with aprotinin(0.1%), bacitracin(0.5%) and sodi um deoxycholate(5%), the relative pharmacological bioavailabilities of insulin were 4.84%,6.60% and 14.95% respectively. The in vitro and in vivo results suggest that proteolytic enzymes are present in the buccal mucosa, which limit absorption of insulin. Co-administation with some enzyme inhibitors can improve the bioavailability of insulin via buccal delivery and sodium deoxycholte is more efficient than some enzyme inhibitore used for improving buccal absorption.
What problem does this paper attempt to address?